Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 202

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Evidence for the Preferential Involvement of 5-HT2A Serotonin Receptors in Stress- and Drug-Induced Dopamine Release in the Rat Medial Prefrontal Cortex

Open access
Pehek, Elizabeth A, Nocjar, Christine, Roth, Bryan L, Byrd, Tara A, Mabrouk, Omar S · 2006 · Neuropsychopharmacology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.npp.1300819

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 73

  1. Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ (1989). Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial prefrontal cortex. J Neurochem 52: 1655–1658. · DOI · Paper page
  2. Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M et al (1998). Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155: 761–767. · DOI · Paper page
  3. Aghajanian G, Marek G (1997). Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36: 589–599. · DOI · Paper page
  4. Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA (2005). Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55: 242–251. · DOI · Paper page
  5. Arnsten AFT, Goldman-Rakic PS (1998). Noise stress impairs prefrontal cortical cognitive function in monkeys. Arch Gen Psychiatry 55: 362–368.
  6. Azmitia EC, Segal M (1978). An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Compr Neurol 179: 641–668. · DOI · Paper page
  7. Beart PM, McDonald D (1982). 5-Hydroxytryptamine and 5-hydroxytryptaminergic–dopaminergic interactions in the ventral tegmental area of rat brain. J Pharm Pharmacol 34: 591–593. · DOI
  8. Bonaccorso S, Meltzer H, Li Z, Dai J, Alboszta A, Ichikawa J (2002). SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Neuropsychopharmacology 27: 430–441. · DOI
  9. Carr DB, Sesack SR (2000). GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse 38: 114–123. · DOI · Paper page
  10. Cohen RM, Nordahl TE, Semple WE, Andreason P, Litman RE, Pickar D (1997). The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task. Arch Gen Psychiatry 54: 481–486. · DOI
  11. Davies MA, Compton-Toth BA, Hufeisen SJ, Meltzer HY, Roth BL (2005). The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M(1) agonism a pre-requisite for mimicking clozapine's actions? Psychopharmacology (Berl) 178: 451–460. · DOI
  12. De Deurwaerdere P, Spampinato U (1999). Role of serotonin2A and serotonin2B/2C receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. J Neurochem 73: 1033–1042. · DOI · Paper page
  13. Di Matteo V, De Blasi A, Di Giulio C, Esposito E (2001). Role of 5-HT2C receptors in the control of central dopamine function. Trends Pharmacol Sci 22: 229–232. · DOI · Paper page
  14. Doherty MD, Pickel VM (2000). Ultrastructural localization of the serotonin2A receptor in dopaminergic neurons in the ventral tegmental area. Brain Res 864: 176–185. · DOI · Paper page
  15. Donzanti BA, Yamamoto BK (1988). An improved and rapid HPLC-ED method for the isocratic seperation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci 43: 913–922. · DOI · Paper page
  16. Gainetdinov RR, Jones SR, Caron MG (1999). Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol Psychiatry 46: 303–311. · DOI · Paper page
  17. Gobert A, Millan MJ (1999). Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the rat frontal cortex of freely-moving rats. Neuropharmacology 38: 315–317. · DOI · Paper page
  18. Gobert A, Rivet J, Lejeune F, Newman-Tancredi A, Adhumeau-Auclair A, Nicolas J et al (2000). Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36: 205–221. · DOI · Paper page
  19. Goldman-Rakic PS, Muly III EC, Williams GV (2000). D1 receptors in prefrontal cells and circuits. Brain Res Rev 31: 295–301. · DOI · Paper page
  20. Gomeza J, Mary S, Brabet I, Parmentier M, Restituito S, Bockaert J et al (1996). Coupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists. Mol Pharmacol 50: 923–930.
  21. Grace AA (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41: 1–24. · DOI · Paper page
  22. Hertel P, Nomikos GG, Iurlo M, Svensson TH (1996). Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology 124: 74–86. · DOI
  23. Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O'Laughlin IA, Meltzer HY (2001). 5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76: 1521–1531. · DOI · Paper page
  24. Ichikawa J, Kuroki T, Dai J, Meltzer HY (1998). Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens. Eur J Pharmacol 351: 163–171. · DOI
  25. Inglis FM, Moghaddam B (1999). Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem 72: 1088–1094. · DOI · Paper page
  26. Jakab RL, Goldman-Rakic PS (1998). 5-Hydroxytryptamine(2A) serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic frugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 95: 735–740. · DOI · Paper page
  27. Jentsch JD, Roth RH (1999). The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypthesis of schizophrenia. Neuropsychopharmacology 20: 201–225. · DOI · Paper page
  28. Kawahara H, Yshidda M, Hideyasu Y, Masakatsu N, Masatoshi T (1993). Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis. Neurosci Lett 162: 81–84. · DOI · Paper page
  29. Kawahara Y, Kawahara H, Westerink BHC (1999). Comparison of effects of hypotension and handling stress on the release of noradrenaline and dopamine in the locus coeruleus and medial prefrontal cortex of the rat. Naunyn-Schmiedeberg's Arch Pharmacol 360: 42–49. · DOI
  30. Kozikowski A, Steensma D, Araldi GL, Tuckmantel W, Wang S, Pshenichkin S et al (1998). Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1.]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist. J Med Chem 41: 1641–1650. · doi:10.1021/jm970719q
  31. Kuroki T, Meltzer HY, Ichikawa J (1999). Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J Pharmacol Exp Ther 288: 774–781.
  32. Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Tamminga CA (2003). Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biol Psychiatry 53: 601–608. · DOI
  33. Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R (1999). Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46: 56–72. · DOI · Paper page
  34. Liegeois J-F, Ichikawa J, Meltzer HY (2002). 5-HT2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner. Brain Res 947: 157–165. · DOI
  35. Martin-Ruiz R, Puig VM, Celada P, Shapiro DA, Roth BL, Mengod G et al (2001). Control of serotonin function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci 21: 9856–9866. · DOI · Paper page
  36. Meltzer HY (1989). Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99: S18–S27. · DOI · Paper page
  37. Meltzer HY, Arvanitis L, Bauer D, Rein W (2004). Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. Am J Psychiatry 161: 975–984. · DOI · Paper page
  38. Meltzer HY, Li Z, Kaneda Y, Ichikawa J (2003). Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuro-Psychopharm Biol Psychiatry 27: 1159–1172. · DOI · Paper page
  39. Millan MJ, Dekeyne A, Gobert A (1998). Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37: 953–955. · DOI · Paper page
  40. Miller DD, Andreasen NC, O'Leary DS, Watkins GL, Boles Ponto LL, Hichawa RD (2001). Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol Psychiatry 49: 704–715. · DOI
  41. Moghaddam B, Bunney BS (1990). Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an In Vivo Microdialysis Study. J Neurochem 54: 1755–1760. · DOI · Paper page
  42. Molina V, Gispert JD, Reig S, Sanz J, Pascau J, Santos A et al (2005a). Cerebral metabolic changes induced by closapine in schizophrenia and related to clinical improvement. Psychopharmcology 178: 17–26. · DOI
  43. Molina V, Gispert JD, Reig S, Sanz J, Pascau J, Santos A et al (2003). Cerebral metabolism and risperidone treatment in schizophrenia. Schizophr Res 60: 1–7. · DOI
  44. Molina V, Sanz J, Sarramea F, Benito C, Palomo T (2005b). Prefrontal atrophy in first episodes of schizophrenia associated with limbic metabolic hyperactivity. J Psychiat Res 39: 117–127. · DOI
  45. Nocjar C, Roth BL, Pehek EA (2002). Localization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience 111: 163–176. · DOI · Paper page
  46. Obrenovitch TP, Urenjak J, Richards DA, Ueda Y, Curzon G, Symon L (1993). Extracellular neuroactive amino acids in the rat striatum during ischaemia: comparison between penumbral conditions and ischaemia with sustained anoxic depolarisation. J Neurochem 61: 178–186. · DOI
  47. Ojima T, Ito C, Sakurai E, Sakurai E, Watanabe T, Yanai K (2004). Effects of serotonin-dopamine antagonists on prepulse inhibition and neurotransmitter contents in the rat cortex. Neurosci Lett. 366: 130–134. · DOI
  48. Pan WHT, Yang S-Y, Lin S-K (2004). Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Synapse 53: 44–52. · DOI
  49. Paxinos G, Watson C. (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press: New York.
  50. Pehek EA, McFarlane EA, Maguschak K, Price B, Pluto CP (2001). M100,907, a selective 5-HT2A antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Res 888: 51–59. · DOI
  51. Pehek EA, Yamamoto BK (1994). Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J Neurochem 63: 2118–2124. · DOI
  52. Potkin SG, Basile VS, Jin Y, Masellis M, Badri F, Keator D et al (2003). D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Mol Psychiatry 8: 109–113. · DOI
  53. Pozzi L, Acconcia S, Ceglia I, Invernizzi RW, Smamanin R (2002). Stimulation of 5-hydroxytryptamine (5HT2C) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex. J Neurochem 82: 93–100. · DOI
  54. Roth B, Hamblin M, Ciaranello R (1991). Developmental regulation of 5-HT2 and 5-HT1c mRNA and receptor levels. Brain Res Dev Brain Res 58: 51–58. · DOI
  55. Roth B, Meltzer H, Khan N (1998). Binding of typical and atypical antipsychotic drugs to multiple neurotransmitter receptors. Adv Pharmacol 42: 482–485. · DOI
  56. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S et al (2002). Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 99: 11934–11939. · DOI · Paper page
  57. Roth BL, Ernsberger P, Steinberg S, Rao S, Rauser L, Savage J et al (2001). The in vitro pharmacology of the β-adrenergic receptor pet ligand (s)-fluorocarazolol reveals high affinity for cloned β-adrenergic receptors and moderate affinity for the human 5-HT1A receptor. Psychopharmacology 157: 111–114. · doi:10.1007/s002130100844
  58. Rothman RB, Baumann MH, Savage JE, Rauser L, McBride A, Hufeisen SJ et al (2000). Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102: 2836–2841. · DOI · Paper page
  59. Sesack SR, Pickel VM (1992). Prefrontal cortical efferents in the rat synapse on Unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 320: 145–160. · DOI · Paper page
  60. Shapiro DA, Kristiansen K, Weiner DM, Kroeze WK, Roth BL (2002). Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J Biol Chem 277: 11441–11449. · DOI · Paper page
  61. Shi Q, Savage JE, Hufeisen SJ, Rauser L, Grajkowska E, Ernsberger P et al (2003). L-homocysteine sulfinic acid and other acidic homocysteine derivatives are potent and selective metabotropic glutamate receptor agonists. J Pharmacol Exp Ther 305: 131–142. · DOI
  62. Sorg B, Kalivas P (1993). Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience 53: 695–703. · DOI · Paper page
  63. Talvik-Lotfi M, Nyberg S, Nordstrom A-L, Ito H, Halldin C, Brunner F et al (2000). High 5-HT2A receptor occupancy in M100907-treated schizophrenic patients. Psychopharmacology 148: 400–403. · DOI
  64. Thierry AM, Tassin JP, Blanc G, Glowinski J (1976). Selective activation of the mesocortical DA system by stress. Nature 263: 242–244. · DOI · Paper page
  65. Weinberger DR (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44: 660–669. · DOI · Paper page
  66. Westerink BHC, de Boer P, de Vries JB, Kruse CG, Long SK (1998). Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain. Eur J Pharm 361: 27–33. · DOI
  67. Westerink BHC, Kawahara Y, De Boer P, Geels C, De Vries JB, Wikstrom HV et al (2001). Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum. Eur J Pharmacol 412: 127–138. · DOI
  68. Willins DL, Deutch AY, Roth BL (1997). Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27: 79–82. · DOI · Paper page
  69. Wroblewska B, Wroblewski JT, Pshenichkin S, Surin A, Sullivan SE, Neale JH (1997). N-acetylaspartylglutamate selectively activates mGluR3 Receptors in transfected cells. J Neurochem 69: 174–181. · DOI · Paper page
  70. Xue C-J, Ng JP, Li Y, Wolf ME (1996). Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J Neurochem 67: 352–363. · DOI · Paper page
  71. Yamamoto BK, Pehek EA (1990). A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis. Brain Res 506: 236–242. · doi:10.1016/0006-8993(90)91256-g
  72. Zahrt J, Taylor JR, Mathew RG, Arnsten AFT (1997). Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17: 8528–8535. · DOI · Paper page
  73. Zhang W, Perry KW, Wong DT, Potts BD, Bao J, Tollefson GD et al (2000). Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology 23: 250–262. · DOI · Paper page

Cited by

Metadata

Authors
Pehek, E. A., Nocjar, C., Roth, B. L., Byrd, T. A., & Mabrouk, O. S.
Venue
Neuropsychopharmacology
Published
2005-07-06
Volume
31
Issue
2
Pages
265-277
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2044852143
Cited by
202
References
8
FWCI
4.08
Type
journal article
Language
en
Open access
bronze
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evidence for the Preferential Involvement of 5-HT2A Serotonin Receptors in Stress- and Drug-Induced Dopamine Release in the Rat Medial Prefrontal Cortex. https://app.cochat.ai/papers/10.1038/sj.npp.1300819
The paper
Pehek, E. A., Nocjar, C., Roth, B. L., Byrd, T. A., & Mabrouk, O. S. (2006). Evidence for the Preferential Involvement of 5-HT2A Serotonin Receptors in Stress- and Drug-Induced Dopamine Release in the Rat Medial Prefrontal Cortex. Neuropsychopharmacology. https://doi.org/10.1038/sj.npp.1300819

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.